CD4 and Opportunistic infection: This treatment leads to decreased plasma levels of HIV mRNA and increased CD4+ T-lymphocyte counts, resulting in increased patient survival and a decrease in the incidence of three major opportunistic infections: Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, and cytomegalovirus retinitis [18, 19].